These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Structure-activity relationships of new A,D-ring modified steroids as aromatase inhibitors: design, synthesis, and biological activity evaluation. Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA J Med Chem; 2005 Oct; 48(20):6379-85. PubMed ID: 16190763 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biochemical studies of 17-substituted androst-3-enes and 3,4-epoxyandrostanes as aromatase inhibitors. Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA Steroids; 2008 Dec; 73(14):1409-15. PubMed ID: 18691607 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of a series of A,B-ring modified 16,17-secoandrostane derivatives. Sakac M; Gaković A; Stojanović S; Djurendić E; Kojić V; Bogdanović G; Gasi KP Bioorg Chem; 2008 Jun; 36(3):128-32. PubMed ID: 18304603 [TBL] [Abstract][Full Text] [Related]
5. New structure-activity relationships of A- and D-ring modified steroidal aromatase inhibitors: design, synthesis, and biochemical evaluation. Varela C; Tavares da Silva EJ; Amaral C; Correia da Silva G; Baptista T; Alcaro S; Costa G; Carvalho RA; Teixeira NA; Roleira FM J Med Chem; 2012 Apr; 55(8):3992-4002. PubMed ID: 22475216 [TBL] [Abstract][Full Text] [Related]
6. Steroidal pyrazolines evaluated as aromatase and quinone reductase-2 inhibitors for chemoprevention of cancer. Abdalla MM; Al-Omar MA; Bhat MA; Amr AG; Al-Mohizea AM Int J Biol Macromol; 2012 May; 50(4):1127-32. PubMed ID: 22361454 [TBL] [Abstract][Full Text] [Related]
7. Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme. Gobbi S; Cavalli A; Rampa A; Belluti F; Piazzi L; Paluszcak A; Hartmann RW; Recanatini M; Bisi A J Med Chem; 2006 Jul; 49(15):4777-80. PubMed ID: 16854084 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and study of some new N-substituted imide derivatives as potential anticancer agents. Jindal DP; Bedi V; Jit B; Karkra N; Guleria S; Bansal R; Palusczak A; Hartmann RW Farmaco; 2005 Apr; 60(4):283-90. PubMed ID: 15848202 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, antitumor activity and molecular docking study of novel benzofuran-2-yl pyrazole pyrimidine derivatives. El-Zahar MI; Adb El-Karim SS; Haiba ME; Khedr MA Acta Pol Pharm; 2011; 68(3):357-73. PubMed ID: 21648190 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 4-imidazolylflavans as nonsteroidal aromatase inhibitors. Pouget C; Yahiaoui S; Fagnere C; Habrioux G; Chulia AJ Bioorg Chem; 2004 Dec; 32(6):494-503. PubMed ID: 15530990 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of azole isoflavone inhibitors of aromatase. Hackett JC; Kim YW; Su B; Brueggemeier RW Bioorg Med Chem; 2005 Jun; 13(12):4063-70. PubMed ID: 15911319 [TBL] [Abstract][Full Text] [Related]
12. Lead optimization of 4-imidazolylflavans: new promising aromatase inhibitors. Yahiaoui S; Pouget C; Buxeraud J; Chulia AJ; Fagnère C Eur J Med Chem; 2011 Jun; 46(6):2541-5. PubMed ID: 21497425 [TBL] [Abstract][Full Text] [Related]
13. New Potent 5α- Reductase and Aromatase Inhibitors Derived from 1,2,3-Triazole Derivative. El-Naggar M; El-All ASA; El-Naem SIA; Abdalla MM; Rashdan HRM Molecules; 2020 Feb; 25(3):. PubMed ID: 32033281 [TBL] [Abstract][Full Text] [Related]
14. Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids. Takahashi M; Yamashita K; Numazawa M Steroids; 2010 Apr; 75(4-5):330-7. PubMed ID: 20096721 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of DL-standishinal and its related compounds for the studies on structure-activity relationship of inhibitory activity against aromatase. Katoh T; Akagi T; Noguchi C; Kajimoto T; Node M; Tanaka R; Nishizawa née Iwamoto M; Ohtsu H; Suzuki N; Saito K Bioorg Med Chem; 2007 Apr; 15(7):2736-48. PubMed ID: 17287126 [TBL] [Abstract][Full Text] [Related]
16. Pharmacology of aminoglutethimide: structure/activity relationships and receptor interactions. Nicholls PJ; Daly MJ; Smith HJ Breast Cancer Res Treat; 1986; 7 Suppl():S55-67. PubMed ID: 3755630 [TBL] [Abstract][Full Text] [Related]